WHO ICTRP trial
A randomised, double-blind, placebo-controlled study of AGI 006 in the treatment…
EUCTR2005-000436-24-IE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-000436-24-IE |
|---|---|
| Public title | A randomised, double-blind, placebo-controlled study of AGI 006 in the treatment of functional dyspepsia. |
| Scientific title | A randomised, double-blind, placebo-controlled study of AGI 006 in the treatment of functional dyspepsia. |
| Primary sponsor | AGI Therapeutics Limtied |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): Therapeutic use (Phase IV): |
| Countries | Ireland;Lithuania;Latvia |
| Conditions | Functional (Non-ulcer) Dyspepsia (FD; NUD) MedDRA version: 6.0 Level: PT Classification code 10013946 |
| Interventions | Product Name: r-baclofen (AGI 006) Product Code: r-baclofen (AGI 006) Pharmaceutical Form: Tablet INN or Proposed INN: r-bacolfen (AGI 006) Current Sponsor code: AGI006-001 Concentration unit: mg milligram(s) Concentration type: equal… |
| Registration date | Feb 15, 2005 |
| Target size | 66 |
| Secondary IDs | AGI006-001 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: